DrugPatentWatch Database Preview

Pharmacia Company Profile

« Back to Dashboard

What is the competitive landscape for PHARMACIA, and when can generic versions of PHARMACIA drugs launch?

PHARMACIA has one hundred and thirty-six approved drugs.

There are eight US patents protecting PHARMACIA drugs.

There are two hundred and eighty-nine patent family members on PHARMACIA drugs in fifty-two countries and sixty supplementary protection certificates in twelve countries.

Summary for Pharmacia

International Patents:	289
US Patents:	8
Tradenames:	111
Ingredients:	86
NDAs:	136

Drugs and US Patents for Pharmacia

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Pharmacia And Upjohn	HYLOREL	guanadrel sulfate	TABLET;ORAL	018104-002	Dec 29, 1982		DISCN	No	No
Pharmacia And Upjohn	XANAX	alprazolam	TABLET;ORAL	018276-001	Approved Prior to Jan 1, 1982	AB	RX	Yes	No
Pharmacia And Upjohn	CLEOCIN PHOSPHATE	clindamycin phosphate	INJECTABLE;INJECTION	061839-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Pharmacia And Upjohn	VANCOR	vancomycin hydrochloride	INJECTABLE;INJECTION	062956-002	Aug 1, 1988		DISCN	No	No

Expired US Patents for Pharmacia

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Pharmacia And Upjohn	ZINECARD	dexrazoxane hydrochloride	INJECTABLE;INJECTION	020212-001	May 26, 1995	4,963,551
Pharmacia And Upjohn	ESTRING	estradiol	INSERT, EXTENDED RELEASE;VAGINAL	020472-001	Apr 26, 1996	5,188,835
Pharmacia And Upjohn	GENOTROPIN PRESERVATIVE FREE	somatropin recombinant	INJECTABLE;INJECTION	020280-008	Jan 27, 1998	5,501,673
Pharmacia And Upjohn	GENOTROPIN	somatropin recombinant	INJECTABLE;INJECTION	020280-007	Oct 23, 1996	5,633,352

Paragraph IV (Patent) Challenges for PHARMACIA drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
	Tablets	1 g		2005-08-23
	Extended-release Capsules	2 mg and 4 mg		2007-07-30
	Injection	2 mg/mL, 300 mL bag		2009-09-01
	Tablets	600 mg		2005-12-21
	Oral Suspension	100 mg/5 mL		2009-08-03
	Injection	2 mg/mL, 100 mL bag		2009-12-29

Non-Orange Book US Patents for Pharmacia

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No.	Title	Estimated Patent Expiration
7,008,637	Transdermally administered tolterodine as anti-muscarinic agent for the treatment of overactive bladder
6,444,813	Linezolid-crystal form II
6,517,864	Transdermally administered tolterodine as anti-muscarinic agent for the treatment of overactive bladder

International Patents for Pharmacia Drugs

Country	Document Number	Estimated Expiration
China	1169522
European Patent Office	1105111
Norway	20022264
Israel	136294

Supplementary Protection Certificates for Pharmacia Drugs

Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
C0001	France		PRODUCT NAME: ETHINYLESTRADIOL BETADEX CLATHRATE; NAT. REGISTRATION NO/DATE: NL 32343 20060710; FIRST REGISTRATION: NL - RVG 31781 20050804
2013 00053	Denmark		PRODUCT NAME: CLINDAMYCIN (SOM CLINDAMYCIN PHOSPHATE) OG TRETINOIN; NAT. REG. NO/DATE: 48954 20130416; FIRST REG. NO/DATE: IE PA1332/043/001 20130322
C/GB10/012	United Kingdom		PRODUCT NAME: A COMBINATION OF ACYCLOVIR AND HYDROCORTISONE; REGISTERED: UK PL18191/0001-0001 20091112
C0128	France		PRODUCT NAME: LATANOPROST; REGISTRATION NO/DATE IN FRANCE: NL 22549 DU 19970724; REGISTRATION NO/DATE AT EEC: 12716 DU 19960718

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Pharm Assoc
• Pharm Res Assoc
• Pharm Spec
• Pharm Ventures